An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
Title:
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
Author:
Lizama, B.N. North, H.A. Pandey, K. Williams, C. Duong, D. Cho, E. Di Caro, V. Ping, L. Blennow, K. Zetterberg, H. Lah, J. Levey, A.I. Grundman, M. Caggiano, A.O. Seyfried, N.T. Hamby, M.E.